Abstract 234 Table 1

EndpointsMulti-drug resistant infection (n=24)No infections (n=191)P-value
Type of Infection
% VRE 12.5% (3/24)
% MRSA 12.5% (3/24)
% Klebsiella 16.7% (4/24)
% Enterobacter 4.2% (1/24)
% Pseudomonas 16.7% (4/24)
% Acinetobacter 16.7% (4/24)
% Other 20.8% (5/24)
Length of Hospital Stay (days) 26.4±25.9 10.9±5.4 <0.001
Length of ICU Stay (days) 15.3±15.5 5.6±4.1 <0.001
30 Day Subsequent Survival 91.7% 92.7% 0.865
Subsequent 1 Year Survival 69.1% 86.6% 0.044
Subsequent 1 Year Freedom from Any-Treated Rejection 84.1% 84.8% 0.984
Subsequent 1 Year Freedom from Acute Cellular Rejection 88.8% 90.0% 0.976
Subsequent 1 Year Freedom from Antibody-Mediated Rejection 100.0% 95.8% 0.309